INSIGHTS & STRATEGIES

WisdomTree Blog

The pandemic accelerated the adoption of Internet-oriented businesses in China, leading to potential major growth ahead for China’s tech stars. Liqian Ren highlights the most important points for investors to consider when investing in China.

Read the article

This month the House of Representatives voted to pass the Holding Foreign Companies Accountable Act, and it is expected to be signed into law. Liqian Ren discusses the impact of this decision on your equity portfolio.

Read the article
The Central Committee of the Chinese Communist Party’s (CCP) communique received much attention from investors in the U.S. last week. Liqian Ren explains why.
Read the article
The recent move to potentially delist Chinese companies from American exchanges has made for good headlines. Liqian Ren explains why we believe this poses minimal risk to Chinese equities—particularly the non-stated-owned segment of China or emerging markets, where China is about one-third of total weight.
Read the article

A newly established superagency, the National Healthcare Security Administration (NHSA), has been charged to lead everything health-care-related in China. If China starts imitating the health care model of U.K.’s National Health Service, the NHSA has the potential to become the world’s biggest employer. Liqian Ren discusses this possibility with two health care experts, Dr. Mark McClellan and Dr. Zhou Yang.

Read the article

Dr. Raghuram Rajan, former governor of the Bank of India, joined Jeremy Schwartz and Liqian Ren last week on the “Behind the Markets” podcast to discuss his new book, The Third Pillar: How Markets and The State Leave the Community Behind.

Read the article